Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 2Neurotoxicity Syndromes 2Colorectal Neoplasms 2Colonic Neoplasms 2Primary Immunodeficiency Diseases 1Pain 1Neoplasms 1Infections 1Epstein-Barr Virus Infections 1Breast Neoplasms 1

Interventions

Rituximab 5Valganciclovir 2Methotrexate 2Leucovorin 2Doxorubicin 2valomaciclovir 1threonic acid 1pembrolizumab 1otelixizumab 1merphos 1cc-486 1avelumab 1Zidovudine 1Vincristine 1Valacyclovir 1Tomography, X-Ray Computed 1Prednisone 1Magnesium Sulfate 1Interferons 1Hydroxyurea 1Etoposide 1Echocardiography 1EPOCH protocol 1Cyclophosphamide 1Caves 1Carboplatin 1Brentuximab Vedotin 1Bortezomib 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Epstein-Barr Virus Infections × Magnesium Sulfate × Clear all
NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡